Neidhart, Jeffrey
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factor. [electronic resource]
- Vaccine Jan 2004
- 773-80 p. digital
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
ISSN: 0264-410X
Standard No.: 10.1016/j.vaccine.2003.08.021 doi
Subjects--Topical Terms: Adjuvants, Immunologic--pharmacology Adult Aged Antibodies, Neoplasm--analysis Antibody Formation--immunology Antigen-Antibody Reactions Antigens, Neoplasm--immunology Baculoviridae--immunology Cancer Vaccines--adverse effects Cell Adhesion Molecules--immunology Cell Division Chemistry, Pharmaceutical Colorectal Neoplasms--immunology Emulsions Enzyme-Linked Immunosorbent Assay Epithelial Cell Adhesion Molecule Escherichia coli--immunology Female Granulocyte Colony-Stimulating Factor--pharmacology Humans Immunity, Cellular--immunology Immunization Interferon-gamma--biosynthesis Lipid A--chemistry Liposomes Lymphocyte Count Male Middle Aged Mineral Oil Pilot Projects Recombinant Proteins Skin Tests Vaccines, Synthetic--immunology